Developing communication frameworks between academics and pharmaceutical companies should not be underestimated as R&D undertaken by leading academics delivers huge value and importance to future drug development. It is in the commercial interest of leading pharmaceutical companies to build frameworks to not only harmonise and standardize biobanks on a global scale, but to ensure communication between universities and pharma are in place. By working together and understanding each other’s needs will mean the quality and diversity of samples and research will attract continual financial rewards for future drug development.
With a programme full of leading academic institutions such as the Royal Liverpool University Hospital, National Cancer Institute and Cancer Research UK pharmaceutical companies Biobanking provides a fantastic opportunity for building and developing frameworks with these leading organizations
With Genzyme, GSK, AstraZeneca, Genentech,Sanofi-
Please visit the website for further information http://www.smi-
# # #
SMi have had an established portfolio of Pharmaceutical, Defence, Energy, Finance and PPP/PFI events running since 1993. We are at the forefront of linking businesses with information, organising over 150 Conferences, Workshops and Masterclasses every year. All our events are research driven and highly targeted towards senior level professionals, designed to help you make informed decisions and remain at the cutting edge of business information.